Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0U8DW
|
||||
Former ID |
DNC003664
|
||||
Drug Name |
1-Butyl-8-phenyl-3,7-dihydro-purine-2,6-dione
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [526958] | ||
Structure |
Download2D MOL |
||||
Formula |
C15H16N4O2
|
||||
Canonical SMILES |
CCCCN1C(=O)C2=C(NC1=O)N=C(N2)C3=CC=CC=C3
|
||||
InChI |
1S/C15H16N4O2/c1-2-3-9-19-14(20)11-13(18-15(19)21)17-12(16-11)10-7-5-4-6-8-10/h4-8H,2-3,9H2,1H3,(H,16,17)(H,18,21)
|
||||
InChIKey |
UGAWDWCYTZJBPQ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A2b receptor | Target Info | Inhibitor | [526958] | |
Adenosine A2a receptor | Target Info | Inhibitor | [526958] | ||
Adenosine A1 receptor | Target Info | Inhibitor | [526958] | ||
KEGG Pathway | Rap1 signaling pathway | ||||
Calcium signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Vascular smooth muscle contraction | |||||
Alcoholismhsa04015:Rap1 signaling pathway | |||||
cAMP signaling pathway | |||||
Parkinson's disease | |||||
Alcoholismhsa04022:cGMP-PKG signaling pathway | |||||
Sphingolipid signaling pathway | |||||
Morphine addiction | |||||
Pathway Interaction Database | C-MYB transcription factor networkhif2pathway:HIF-2-alpha transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.